首页|期刊导航|中国临床药理学与治疗学|骨关节炎免疫治疗及新型技术研究进展

骨关节炎免疫治疗及新型技术研究进展OA

Research progress in immunotherapy and emerging technologies for osteoarthritis

中文摘要英文摘要

骨关节炎(osteoarthritis,OA)是一种以关节疼痛、功能障碍和软骨退变为主要特征的慢性疾病,目前仍缺乏能够有效改变其疾病进程的治疗手段.近年来,随着免疫学、分子生物学及干细胞与基因工程技术的进展,OA 的治疗研究不断推进.特异性靶向药物与非特异性抗炎药物在部分临床试验中表现出一定的抗炎或镇痛作用,但整体疗效有限且存在安全性顾虑.与此同时,免疫治疗、细胞治疗和基因治疗等新型技术为OA 干预提供了新的思路,并在抑制炎症、保护软骨及改善疼痛方面显示出潜在优势,但其长期安全性、疗效稳定性及患者分层策略仍需进一步明确.未来,OA 的治疗有望向精准分型、联合干预、局部长效免疫调节以及新型药物递送方向发展.本综述总结了相关研究进展,为未来 OA 治疗策略优化提供参考.

Osteoarthritis(OA)is a chronic condi-tion characterized by joint pain,functional impair-ment,and degeneration of articular cartilage.Cur-rently,there remains a lack of effective treatments capable of altering the disease progression.In re-cent years,advances in immunology,molecular bi-ology,stem cell technology,and genetic engineer-ing have driven forward research on OA therapies.Although targeted agents and non-specific anti-in-flammatory drugs have shown certain anti-inflam-matory or analgesic effects in some clinical trials,their overall efficacy remains limited and safety concerns persist.Meanwhile,emerging approaches such as immunotherapy,cell-based therapy,and gene therapy offer novel strategies for OA interven-tion,showing potential advantages in suppressing inflammation,preserving cartilage,and alleviating pain.However,issues such as long-term safety,durability of therapeutic effects,and patient stratifi-cation require further clarification.In the future,OA treatment is expected to evolve toward precise phe notyping,combined interventions,localized long-term immunomodulation,and innovative drug de-livery approaches.This review summarizes recent advances in the field to provide insights for optimiz-ing future therapeutic strategies for OA.

高自顺;李云霞

甘肃省中医院,兰州 730050,甘肃兰州大学,兰州 730000,甘肃

医药卫生

骨关节炎免疫治疗细胞与基因治疗临床试验

osteoarthritisimmunotherapycell and gene therapyclinical trials

《中国临床药理学与治疗学》 2026 (9)

1286-1296,11

甘肃省卫生健康行业科研项目(GSWSKY2024-55)

10.12092/j.issn.1009-2501.2026.09.015

评论